Search

Your search keyword '"Luciano F. Drager"' showing total 373 results

Search Constraints

Start Over You searched for: Author "Luciano F. Drager" Remove constraint Author: "Luciano F. Drager"
373 results on '"Luciano F. Drager"'

Search Results

301. Obstructive sleep apnea is highly prevalent and correlates with impaired glycemic control in consecutive patients with the metabolic syndrome

304. Sleep-Disordered Breathing in Patients with Hypertrophic Cardiomyopathy

305. Validation of a Portable Monitoring (PM) for the Diagnosis of Sleep Disordered Breathing in Consecutive Patients Waiting for Cardiopulmonary Bypass Grafting (CABG)

307. Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome

308. Abstract 5430: Obstructive Sleep Apnoea Exacerbates Muscular Sympathetic Nervous Activity in Patients with Metabolic Syndrome

309. Abstract 2462: Obstructive Sleep Apnea Treatment Improves the Blood Pressure Behavior in Normotensive Patients: A Randomized Study

310. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea

311. Accuracy of anemia diagnosis by physical examination

312. Sympathetic activity, heart failure, obesity, and metabolic syndrome: is there any role for obstructive sleep apnea?

313. PP.20.21

314. PP.20.22

315. Letter Regarding Article by Law et al, 'Headaches and the Treatment of Blood Pressure: Results From a Meta-Analysis of 94 Randomized Placebo-Controlled Trials With 24 000 Participants'

316. Early signs of atherosclerosis in obstructive sleep apnea

317. The importance of amiodarone pulmonary toxicity in the differential diagnosis of a patient with dyspnea awaiting a heart transplant

318. [Genetic aspects of endocrine hypertensive disorders]

319. Obstructive Sleep Apnea and Surgery: Wake up for the problem!

320. Obstructive sleep apnea and chronic stress exacerbate sympathetic activation and baroreflex dysfunction in patients with metabolic syndrome

321. Effects of CPAP on Inflammation in Patients With Obstructive Sleep Apnea: Is it a Matter of Time or a Matter of Marker?

322. Sleep apnea in focus

323. Sleep Apnea: Why Should We Look for Cardiac Biomarkers?

324. Atherosclerosis in obstructive sleep apnoea: It does not matter whether patients are sleepy or not

325. Is the Cardiovascular System the Primary Target of Obstructive Sleep Apnea?

326. 136 DETERMINANTS OF FUNCTIONAL AND STRUCTURAL PROPERTIES OF LARGE ARTERIES AND THE CORRELATIONS WITH END-ORGAN DAMAGE IN STAGE III HYPERTENSIVE PATIENTS

327. OBSTRUCTIVE SLEEP APNEA IS THE MOST FREQUENT SECONDARY CAUSE OF RESISTANT HYPERTENSION

328. The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome

329. Apparent Non-Cited Overlap between Two Published Articles by the Same Group of Authors

330. 172 POOR SLEEP QUALITY AND QUALITY OF LIFE ARE ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA IN HYPERTROPHIC CARDIOMYOPATHY

331. 262 RECIPROCAL INTERACTIONS OF OBSTRUCTIVE SLEEP APNEA AND ASSOCIATED HYPERTENSION

333. Sleep Apnea and the Risk of Stroke in the Elderly

334. 131 Continuous positive airway pressure therapy reverses the impaired arterial stiffness in normotensive patients with obstructive sleep apnea

339. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.

341. Intermittent claudication and severe renal artery stenosis are independently associated in hypertensive patients referred for renal arteriography

342. Reply.

343. RNA interference therapy in cardiology: will new targets improve therapeutic goals?

344. Blood Pressure Control: The secret is…Team Work!

345. CPAP for Obstructive Sleep Apnea and the Metabolic Syndrome

346. Attenuated Heart Rate Recovery is Associated with Sympathetic Hyperactivity in Patients with Metabolic Syndrome and Obstructive Sleep Apnea

347. Critical analysis of autoregressive and fast Fourier transform markers of cardiovascular variability in rats and humans

348. Potential Drug-Drug Interactions in Patients with Coronary Artery Disease

349. Exercise training and hypocaloric diet improves sympathetic arterial baroreflex control in patients with metabolic syndrome and obstructive sleep apnea

Catalog

Books, media, physical & digital resources